Understanding STON1: Potential Drug Target and Biomarker for Diseases

Target Name: STON1

NCBI ID: G11037

STON1

Understanding STON1: Potential Drug Target and Biomarker for Diseases

STON1, also known as stoned B homolog 1, is a gene that has been identified in human beings as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and mental health conditions. The STON1 gene is located on chromosome 18 and encodes a protein known as STON1, which is expressed in various tissues throughout the body.

Recent studies have suggested that STON1 may play a crucial role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and mental health conditions. For example, studies have shown that STON1 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, STON1 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Furthermore, STON1 has also been linked to several mental health conditions, including depression, anxiety, and schizophrenia. Studies have shown that individuals with certain genetic variations in the STON1 gene are at increased risk for developing these conditions.

Despite these promising findings, more research is needed to fully understand the role of STON1 in disease development and progression. Researchers are currently studying the potential clinical applications of targeting STON1 using small molecules or antibodies, with the goal of developing new treatments for various diseases.

In addition to its potential as a drug target, STON1 has also been identified as a potential biomarker for disease diagnosis and monitoring. Studies have shown that STON1 is expressed in various tissues and cells, including brain, spinal cord, and blood cells. Additionally, STON1 has been shown to be involved in the regulation of cellular processes that are relevant to disease development, such as cell division, apoptosis (programmed cell death), and inflammation.

These properties make STON1 an attractive candidate for use as a biomarker for disease diagnosis and monitoring. By measuring the expression of STON1 in various tissues and cells, researchers can monitor disease progression and response to therapeutic treatments. Additionally, by using STON1 as a target for small molecules or antibodies, researchers can develop new treatments for various diseases.

In conclusion, STON1 is a gene that has been identified in human beings as a potential drug target or biomarker for various diseases. Its promising findings make it an attractive candidate for further research and development as a new treatment for a variety of conditions. Further studies are needed to fully understand the role of STON1 in disease development and progression, as well as its potential as a biomarker for disease diagnosis and monitoring.

Protein Name: Stonin 1

Functions: May be involved in the endocytic machinery

The "STON1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STON1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets